CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Welfare, M.
Right arrow Articles by Daly, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Welfare, M.
Right arrow Articles by Daly, A. K.
Cancer Epidemiology Biomarkers & Prevention Vol. 8, 289-292, April 1999
© 1999 American Association for Cancer Research

Polymorphisms in GSTP1, GSTM1, and GSTT1 and Susceptibility to Colorectal Cancer1

Mark Welfare2, A. Monesola Adeokun, Margaret F. Bassendine and Ann K. Daly

Departments of Pharmacological Sciences [M. W., A. M. A., A. K. D.] and Medicine [M. W., M. F. B.], University of Newcastle upon Tyne, Newcastle upon Tyne NE298NH, England

Polymorphisms in glutathione S-transferases (GSTs) may predispose to colorectal cancer through deficient detoxification of environmental carcinogens, although previous results are conflicting. A study with 178 matched case-control pairs was conducted to determine the effect of the GSTT1 and GSTM1 null genotypes and polymorphisms in GSTP1 on colorectal cancer susceptibility. In a secondary analysis, we examined interactions between genotypes and with the N-acetyltransferase 2 (NAT2) genotype. Heterogeneity by age, sex, site, and stage of cancer was also examined. No effect of any genotype for GSTM1, GSTT1, or GSTP1 on colorectal cancer susceptibility was detected. Secondary end points showed that individuals with both the GSTT1 null and NAT2 slow genotypes combined appeared to be at increased risk of colorectal cancer (odds ratio = 2.33; 95% confidence interval, 1.1–5.0). We conclude that GST polymorphisms alone do not predispose to colorectal cancer in northeast England. We also observed possible effects of the GSTT1 null genotype on the age and stage at presentation, and these, together with the findings of an apparent interaction with NAT2 genotypes, need to be confirmed in further studies.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
T. Lecomte, B. Landi, P. Beaune, P. Laurent-Puig, and M.-A. Loriot
Glutathione S-Transferase P1 Polymorphism (Ile105Val) Predicts Cumulative Neuropathy in Patients Receiving Oxaliplatin-Based Chemotherapy.
Clin. Cancer Res., May 15, 2006; 12(10): 3050 - 3056.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. L. Nock, X. Liu, M. S. Cicek, L. Li, F. Macarie, B. A. Rybicki, S. J. Plummer, G. T. MacLennan, G. Casey, and J. S. Witte
Polymorphisms in polycyclic aromatic hydrocarbon metabolism and conjugation genes, interactions with smoking and prostate cancer risk.
Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 756 - 761.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. Rajagopal, M. Deakin, A.S. Fawole, J.B. Elder, J. Elder, V. Smith, R.C. Strange, and A.A. Fryer
Glutathione S-transferase T1 polymorphisms are associated with outcome in colorectal cancer
Carcinogenesis, December 1, 2005; 26(12): 2157 - 2163.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E.M.J. van der Logt, S.M. Bergevoet, H.M.J. Roelofs, Z. van Hooijdonk, R.H.M. te Morsche, T. Wobbes, J.B. de Kok, F.M. Nagengast, and W.H.M. Peters
Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk
Carcinogenesis, December 1, 2004; 25(12): 2407 - 2415.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J.-Q. He, J. E. Connett, N. R. Anthonisen, P. D. Pare, and A. J. Sandford
Glutathione S-Transferase Variants and Their Interaction with Smoking on Lung Function
Am. J. Respir. Crit. Care Med., August 15, 2004; 170(4): 388 - 394.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Rollinson, J. M. Allan, G. R. Law, P. L. Roddam, M. T. Smith, C. Skibola, A. G. Smith, M. S. Forrest, K. Sibley, R. Higuchi, et al.
High-Throughput Association Testing on DNA Pools to Identify Genetic Variants that Confer Susceptibility to Acute Myeloid Leukemia
Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 795 - 800.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
O. L. van der Hel, H. B. Bueno de Mesquita, M. Roest, B. Slothouber, C. van Gils, P. A. H. van Noord, D. E. Grobbee, and P. H. M. Peeters
No Modifying Effect of NAT1, GSTM1, and GSTT1 on the Relation between Smoking and Colorectal Cancer Risk
Cancer Epidemiol. Biomarkers Prev., July 1, 2003; 12(7): 681 - 682.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Seow, J.-M. Yuan, C.-L. Sun, D. Van Den Berg, H.-P. Lee, and M. C. Yu
Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese Health Study
Carcinogenesis, December 1, 2002; 23(12): 2055 - 2061.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. M. de Jong, I. M. Nolte, G. J. te Meerman, W. T. A. van der Graaf, E. G. E. de Vries, R. H. Sijmons, R. M. W. Hofstra, and J. H. Kleibeuker
Low-penetrance Genes and Their Involvement in Colorectal Cancer Susceptibility
Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1332 - 1352.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. Sachse, G. Smith, M. J.V. Wilkie, J. H. Barrett, R. Waxman, F. Sullivan, D. Forman, D. T. Bishop, and C.R. Wolf
A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer
Carcinogenesis, November 1, 2002; 23(11): 1839 - 1850.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. Stoehlmacher, D. J. Park, W. Zhang, S. Groshen, D. D. Tsao-Wei, M. C. Yu, and H.-J. Lenz
Association Between Glutathione S-Transferase P1, T1, and M1 Genetic Polymorphism and Survival of Patients With Metastatic Colorectal Cancer
J Natl Cancer Inst, June 19, 2002; 94(12): 936 - 942.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Krajinovic, D. Labuda, G. Mathonnet, M. Labuda, A. Moghrabi, J. Champagne, and D. Sinnett
Polymorphisms in Genes Encoding Drugs and Xenobiotic Metabolizing Enzymes, DNA Repair Enzymes, and Response to Treatment of Childhood Acute Lymphoblastic Leukemia
Clin. Cancer Res., March 1, 2002; 8(3): 802 - 810.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Loktionov, M. A. Watson, M. Gunter, W. S.L. Stebbings, C. T.M. Speakman, and S. A. Bingham
Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor
Carcinogenesis, July 1, 2001; 22(7): 1053 - 1060.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1999 by the American Association for Cancer Research.